Venture Debt: What It Is, Who Uses It, and When It Makes Sense vs. Equity

When Founders Should Not Use Venture Debt

The situations where venture debt destroys value are predictable and worth naming plainly.

Pre-revenue companies should not use venture debt. Lenders require evidence of ARR or contracted revenue because the interest payments have to come from somewhere. A pre-revenue company taking on a term loan is taking on obligations it cannot service from operations, which means it must raise equity to repay debt — a structurally dangerous position that subordinates future investors to a lender whose covenants can trigger acceleration.

Companies with fragile cash flow should not use venture debt. If the company is already burning through cash quickly and cannot confidently project 18 months of interest payments, a debt facility adds a fixed obligation on top of an already stressed burn rate. A single missed milestone can trigger a covenant violation.

The MAC clause is where founders get surprised. Read it. Most venture debt agreements include a Material Adverse Change clause that gives the lender the right to call the loan if there has been a material adverse change to the borrower's business, prospects, or financial condition. The definition is intentionally broad. A significant customer churn event, a failed product launch, or a key executive departure could give a lender grounds to accelerate repayment. Founders who have not read this clause carefully and thought through how it applies to their business should not close a venture debt facility.

Financial covenants carry their own acceleration risk. Minimum liquidity thresholds, revenue run-rate floors, and EBITDA requirements for later-stage companies can all put a company in technical default if missed, forcing a forbearance negotiation with the lender at the worst possible moment. Model the downside scenarios before signing. If a 20% revenue miss puts you in violation, the facility may be more dangerous than the dilution you were trying to avoid.

The SVB Collapse and What It Did to the Venture Debt Market

Silicon Valley Bank's failure on March 10, 2023 sent an immediate shock through the venture lending market. SVB was not just a lender. It was the operating bank for a substantial portion of the U.S. startup ecosystem. Its collapse froze deal flow, triggered a flight to quality among remaining lenders, and caused spreads to widen 200-400 basis points within the following two quarters as surviving institutions repriced risk.

Pacific Western Bank, which had expanded its venture lending book aggressively in 2021-2022, pulled back sharply in 2023 amid its own deposit outflows and investor concern. The combined effect of SVB's exit and PacWest's contraction removed two significant capital sources from the market simultaneously.

First Citizens BancShares acquired SVB's loan portfolio and commercial banking operations in March 2023 and has maintained the venture banking division under the SVB brand. The transition preserved some continuity for existing borrowers, but deal origination slowed materially through 2023 and into 2024 while First Citizens absorbed the book and reset underwriting standards.

The recovery since then has been steady. By 2025, total U.S. venture debt volume reached $68.8 billion, the highest on record. Specialist non-bank lenders including Hercules Capital, TriplePoint, and Runway Growth Capital absorbed meaningful market share from the retreating bank lenders. BDC-structured lenders, which fund themselves through public capital markets rather than deposits, proved structurally more resilient to the deposit-run dynamics that brought down SVB.

For founders evaluating venture debt today, the post-SVB market has two practical implications. First, terms are tighter than they were in 2020-2021. Interest-only periods are shorter, covenant structures are stricter, and lenders are doing more diligence on customer concentration and churn. Second, the lender mix has shifted toward non-bank specialists, which tend to be more expensive but also more transparent about their underwriting criteria and less susceptible to the macro liquidity pressures that affect deposit-funded banks.

What Accredited Investors Should Know About Venture Lending BDCs

Accredited investors who want exposure to the venture debt market without originating loans directly have one accessible path: publicly traded business development companies that specialize in venture lending.

Hercules Capital (NYSE: HTGC) is the most prominent. As a BDC, it is required to distribute at least 90% of its taxable income to shareholders, which means it generates meaningful dividend yields, historically in the 8-11% range on net asset value. Its portfolio is concentrated in technology, life sciences, and SaaS, and its quarterly filings provide granular data on portfolio quality, non-accrual rates, and weighted average yields. For investors who want to understand venture lending as an asset class, reading a few Hercules 10-Q filings is among the most direct forms of due diligence available.

The risks are real and specific. BDCs use leverage. Hercules typically operates at 1.0-1.2x debt-to-equity, which amplifies both returns and losses. In a recessionary environment, non-accrual rates on venture portfolios can spike quickly. early-stage companies with no recurring revenue are first to default when fundraising freezes. The 2023 vintage saw elevated non-accruals across the sector.

BDC shares also trade at premiums or discounts to net asset value depending on market sentiment. Buying at a significant premium to NAV reduces the margin of safety. Buying at a discount can offer an attractive entry point. Understanding NAV per share and the discount-to-NAV relationship is foundational to evaluating any BDC position.

For accredited investors interested in private venture lending exposure, some firms including Runway Growth Capital have offered fund vehicles to qualified purchasers, a higher standard than accredited investor status. Those structures provide the economics of direct lending without the liquidity of a publicly traded security. The trade-off is illiquidity for typically higher net returns and fewer mark-to-market fluctuations.

If you are building a private markets portfolio and want to understand where venture debt fits alongside equity positions, the AIN guides on venture capital investing and accredited investor resources provide additional context on portfolio construction across asset classes.

The Bottom Line

Venture debt is a specific tool for a specific type of company at a specific stage. It is not a substitute for equity when the business has not yet established the revenue and growth profile that supports debt service. It is not a rescue mechanism for companies whose fundamentals are deteriorating. And it is not cheap. At 10-14% all-in, it carries a meaningful cash cost that founders need to model against the dilution alternative.

But for a Series A or Series B company with $5-30M in ARR, growing steadily, with a clear 18-month plan for the capital and a credible path to a next raise or cash flow breakeven, venture debt is often the most capital-efficient financing available. The $68.8 billion deployed in 2025 reflects how many founders and CFOs have reached exactly that conclusion.

Read the MAC clause. Model the covenant scenarios. Know your lender's track record through a down cycle. Then decide.

For further reading on non-dilutive funding options, the H1 2026 Non-Dilutive Funding Report covers revenue-based financing and other structures alongside venture debt. The Venture Debt Hub benchmarks provide current-year market data on rates, terms, and deal volume by sector.

See also the AIN guide to startup due diligence for angel investors for the equity-side perspective on how founders weigh their financing options before coming to the table.